More treatments for women at risk of breast cancer
Updated guidance from NICE gives more options to women to reduce their risk of breast cancer. NICE recommends tamoxifen or raloxifene as preventative treatments for certain women at high risk of breast cancer due to a family history.
Nicotine products can help people to cut down before quitting smoking
Licensed nicotine products, such as patches and gum, should be offered to people who smoke and are struggling to quit to help them cut down on cigarettes, NICE says. NICE recommends that stop smoking advisers and health professionals advise people to stop smoking in one go, but for those who aren’t ready or are unable to stop in one step, they should suggest considering a harm-reduction approach.
Offer range of effective treatments for people with hep B
More people with hepatitis B should be assessed, referred and offered the range of clinical and cost effective treatments available for the disease, according to NICE. In its first clinical guideline on hepatitis B, NICE recommends a range of measures to help raise awareness of the condition and reduce the current variation in treatments offered.
Older patients at high risk of hospital falls
Updated guidelines from NICE recommend that healthcare professionals should consider patients aged 65 or older, and those aged over 50 with underlying conditions such as stroke, at high risk of falling while in hospital care.
Podcasts available on falls and antisocial behaviour and conduct disorders
We’ve produced implementation podcasts on our updated falls guidance and our guideline on antisocial behaviour and conduct disorders to help you get the most out of these products.
Two shared learning examples from London and Portsmouth on hepatitis B are also now available, which highlight innovative uses of NICE guidance.
Let us know what you think of our draft guidance on behaviour change. The behaviours covered are alcohol, diet, physical activity, sexual behaviour and smoking, and the consultation closes on 31 July 2013.
We’d also like to hear your thoughts on our draft update of our guideline on neuropathic pain. Neuropathic pain is pain caused by a lesion or disease of the central somatosensory nervous system. The consultation closes on 18 July 2013.